News and blogs
438 results found.
Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma
Blood Cancer UK are partnering with Amwins Global Risks to raise funds for myeloma
Stay updated with our organisational strategy
The latest news on our organisational strategy.
Research links childhood CT scan exposure to increased blood cancer risk
In new research, scientists have linked increased CT scan exposure to an increased risk of blood cancer in younger people.
How our research gave vaccine answers to people with blood cancer
Read about how our scientists were able to understand the effectiveness of the COVID-19 vaccine for clinically extremely vulnerable people.
The stolen legacy of Henrietta Lacks
Taken without her knowledge, Henrietta's 'immortal' cells have had an everlasting impact on research and medical ethics.
New non-Hodgkin lymphoma drug
A drug for non-Hodgkin lymphoma, epcoritamab, has been authorised for use in the UK for adults.
This MDS World Awareness Day, four people share their story
October 25 every year is World MDS Awareness Day. This year, four people share their story of living with MDS.
Zanabrutinib recommended for adults with CLL in the UK
Zanubrutinib has been recommended for adults with the blood cancer, chronic lymphocytic leukaemia (CLL) in England.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.
People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.
Blood Cancer UK call for UK-wide mask guidance and increased symptomatic testing
As we head into winter, Blood Cancer UK call for guidance to help protect those affected by blood cancer
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
The story of Dr Jane C Wright, pioneer of blood cancer research
To mark the start of Black History Month, we share the story of Dr Jane C Wright, a true pioneer in the field of blood cancer research
The father of the blood bank - Charles R. Drew
For Black History Month, we are celebrating Charles R. Drew who was an African American surgeon and researcher who pioneered in the field of blood transfusions, blood storage and created the first blood banks.
Ed Davey reveals experience of blood cancer
Blood Cancer UK have welcomed the Lib Dem leaders cancer pledge after he revealed insight into blood cancer experience.
Myeloma drug approved for use
A new treatment for those with the blood cancer myeloma has been approved for use by NICE. It could benefit thousands.
Solomon's unexpected multiple myeloma diagnosis
After a shock diagnosis of multiple myeloma, Solomon talks about the importance of open and honest communication when facing blood cancer.
Ruxolitinib approved for treatment of polycythaemia vera in England and Wales
The drug, ruxolitinib, has been recommended for use by NICE to treat the blood cancer polycythaemia vera in those whose disease is resistant or intolerant to the treatments hydroxycarbamide/hydroxyurea.
The Scottish Medicines Consortium has approved two blood cancer treatments for use on the NHS in Scotland.
The Scottish Medicines Consortium has approved two blood cancer treatments for use on the NHS in Scotland.
Clinical trials can give people with blood cancer hope
Rachel contacted the Clinical Trials Support Service to find out whether she could potentially take part in a clinical trial and contribute to blood cancer research.
"The dark times can be overcome by anyone! - David's running epiphany
David Lauder has run the Great North Run 19 times to raise awareness of Blood Cancer.
